Series date: 
01/01/2024 - 7:00am EST to 12/31/2024 - 11:59pm EST

Series Overview

The Pediatric Solid Tumor Board Meeting is a time for multidisciplinary teams that care for a patient to come together and discuss the diagnosis and treatment plan or new and follow up pediatric oncology patients.  

Target Audience

This course is designed for physicians, nurses and pharmacists. Other learner groups such as physician assistants, medical students, residents, social workers and clinical research staff will also benefit from this course. 

Planning Committee

Jagadeesh Ramdas, MD, Activity Director
Girmay Tekle-Yohannes, MD
Jennifer Kovatch, MD
Michal Miller, MD
Jessica Curtis, RPh
Barbara Molesevich, RN, CPHON

Accreditation 

In support of improving patient care, Geisinger College of Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

 

Credit Designation 

Geisinger College of Health Sciences designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the educational activity.

Geisinger College of Health Sciences designates this activity for 1 contact hours for nurses. Nurses should only claim credit commensurate with the extent of their participation in the educational activity. 

This live activity is approved for 1 contact hours (0.01 CEUs) of continuing pharmacy education credit JA0008072-0000-24-035-L05-P.

Disclosure Policy

Geisinger College of Health Sciences must ensure balance, independence, objectivity, and scientific rigor in all its continuing education activities. Each person in a position to control the educational content of a CE activity must disclose the existence or non-existence of any financial relationship that they have with an ineligible company. There is no minimum financial threshold; individuals must disclose all financial information, regardless of the amount. Individuals must disclose regardless of their view of the relevance of the relationship to the education. Any identified conflicts of interest will be resolved prior to the start of the activity. Subsequently, disclosure information is made available prior to the start of the activity. 

Series location: 
Microsoft Teams Meeting
100 N. Academy Ave
Danville, PA 17822
United States

Sessions

Session Date
Pediatric Solid Tumor Board Meeting - February 14, 2024 02/14/2024 - 12:00pm to 1:00pm EST
Pediatric Solid Tumor Board Meeting R4054-24, April 10, 2024 04/10/2024 - 12:00pm to 1:00pm EDT
Pediatric Solid Tumor Board Meeting R4054-24, May 8, 2024 05/08/2024 - 12:00pm to 1:00pm EDT
Pediatric Solid Tumor Board Meeting- R4054-24 - August 14 2024 08/14/2024 - 12:00pm to 1:00pm EDT
Pediatric Solid Tumor Board Meeting-R4054-24 September 11, 2024 09/11/2024 - 12:00pm to 1:00pm EDT
Pediatric Solid Tumor Board Meeting 10/09/2024 - 12:00pm to 1:00pm EDT
Pediatric Solid Tumor Board Meeting 11/13/2024 - 12:00pm to 1:00pm EST
Pediatric Solid Tumor Board Meeting 12/11/2024 - 12:00pm to 1:00pm EST